Safety and Early Signs of Efficacy of IL12-L19L19.

Clinical trial NCT04471987 · RECRUITING

Trial details

NCT number: NCT04471987
Sponsor: Philogen S.p.A.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2020-07-01
Primary completion: 2026-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.